Payment overview · 2025
General Payments
$133.56
8 reported records · 4 companies
Healthcare provider profile · identity verified
Kevin Jay Faris, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · NOBLE, OK · NPI 1003888207
Verified facts
What the public records show
CMS Open Payments records show Kevin Jay Faris, M.D. received $133.56 in general payments during 2025 across 8 reported records.
Amgen Inc. accounted for 52.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 84 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $69.83 | 52.3% | 4 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $31.96 | 23.9% | 2 | 2025 |
| KYOWA KIRIN, INC. | Unresolved — no canonical attribution shown | $17.05 | 12.8% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $14.72 | 11.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $133.56 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $69.83 | 4 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $69.83 | 4 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $31.96 | 2 | 2025 |
Source payment records
|
|||||
| CRYSVITA Normalized: crysvita |
Drug | KYOWA KIRIN, INC. | $17.05 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $14.72 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $14.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
20 | 20 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
84 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 598 | 158 |
| Gabapentin | Gabapentin | 447 | 90 |
| Pantoprazole Sodium | Pantoprazole Sodium | 433 | 105 |
| Levothyroxine Sodium | Levothyroxine Sodium | 410 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 339 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 306 | 69 |
| Lisinopril | Lisinopril | 284 | 73 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 280 | 66 |
| Omeprazole | Omeprazole | 267 | 68 |
| Cefuroxime | Cefuroxime Axetil | 256 | 180 |
| Prednisone | Prednisone | 235 | 149 |
| Fluticasone Propionate | Fluticasone Propionate | 233 | 107 |
| Losartan Potassium | Losartan Potassium | 229 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 226 | 52 |
| Nabumetone | Nabumetone | 212 | 62 |
| Metformin Hcl | Metformin Hcl | 202 | 69 |
| Metformin Hcl Er | Metformin Hcl | 181 | 50 |
| Meloxicam | Meloxicam | 159 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 159 | 37 |
| Jardiance | Empagliflozin | 153 | 32 |
| Clonazepam | Clonazepam | 150 | 18 |
| Alprazolam | Alprazolam | 149 | 22 |
| Trulicity | Dulaglutide | 149 | 29 |
| Allopurinol | Allopurinol | 148 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 148 | 34 |
| Tramadol Hcl | Tramadol Hcl | 145 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 132 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 132 | 21 |
| Montelukast Sodium | Montelukast Sodium | 130 | 25 |
| Furosemide | Furosemide | 128 | 36 |
| Potassium Chloride | Potassium Chloride | 121 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 119 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 118 | 24 |
| Trazodone Hcl | Trazodone Hcl | 117 | 27 |
| Baclofen | Baclofen | 113 | 23 |
| Pregabalin | Pregabalin | 113 | 18 |
| Azelastine Hcl | Azelastine Hcl | 112 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 111 | 27 |
| Glimepiride | Glimepiride | 111 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 23 |
| Celecoxib | Celecoxib | 102 | 22 |
| Simvastatin | Simvastatin | 102 | 35 |
| Temazepam | Temazepam | 101 | 12 |
| Sertraline Hcl | Sertraline Hcl | 100 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 96 | 16 |
| Carvedilol | Carvedilol | 95 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 23 |
| Doxycycline Hyclate | Doxycycline Hyclate | 90 | 57 |
| Finasteride | Finasteride | 88 | 19 |
| Ezetimibe | Ezetimibe | 87 | 20 |
| Buspirone Hcl | Buspirone Hcl | 86 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 85 | 26 |
| Eliquis | Apixaban | 84 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 81 | 61 |
| Clonidine Hcl | Clonidine Hcl | 80 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 77 | 15 |
| Ozempic | Semaglutide | 75 | 16 |
| Methocarbamol | Methocarbamol | 73 | 34 |
| Amitriptyline Hcl | Amitriptyline Hcl | 70 | suppressed |
| Ibuprofen | Ibuprofen | 70 | 21 |
| Levofloxacin | Levofloxacin | 70 | 55 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 70 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 69 | 13 |
| Ondansetron Odt | Ondansetron | 66 | 22 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 63 | 41 |
| Mirtazapine | Mirtazapine | 61 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 59 | 23 |
| Donepezil Hcl | Donepezil Hcl | 53 | suppressed |
| Atenolol | Atenolol | 52 | 17 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 50 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 50 | 17 |
| Cilostazol | Cilostazol | 49 | suppressed |
| Glipizide | Glipizide | 48 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 13 |
| Propranolol Hcl | Propranolol Hcl | 47 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 47 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 46 | 14 |
| Repatha Sureclick | Evolocumab | 46 | suppressed |
| Sucralfate | Sucralfate | 46 | 15 |
| Farxiga | Dapagliflozin Propanediol | 44 | suppressed |
| Etodolac | Etodolac | 43 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 43 | 24 |
| Paroxetine Hcl | Paroxetine Hcl | 43 | 14 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 42 | 11 |
| Mupirocin | Mupirocin | 42 | 26 |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | 11 |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 40 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 39 | suppressed |
| Famotidine | Famotidine | 39 | 12 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Lorazepam | Lorazepam | 38 | 13 |
| Belsomra | Suvorexant | 37 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 36 | suppressed |
| Piroxicam | Piroxicam | 36 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 35 | 15 |
| Digoxin | Digoxin | 35 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Spironolactone | Spironolactone | 35 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 11 |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 33 | suppressed |
| Nateglinide | Nateglinide | 33 | 12 |
| Glipizide Er | Glipizide | 32 | suppressed |
| Mounjaro | Tirzepatide | 32 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 32 | suppressed |
| Cefdinir | Cefdinir | 31 | 23 |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Leflunomide | Leflunomide | 30 | suppressed |
| Lovastatin | Lovastatin | 30 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 30 | 11 |
| Fluocinonide | Fluocinonide | 29 | 15 |
| Gemfibrozil | Gemfibrozil | 29 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | suppressed |
| Metronidazole | Metronidazole | 29 | 18 |
| Valacyclovir | Valacyclovir Hcl | 29 | 16 |
| Fluconazole | Fluconazole | 28 | 18 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 27 | suppressed |
| Diazepam | Diazepam | 27 | suppressed |
| Levetiracetam | Levetiracetam | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Cefadroxil | Cefadroxil | 26 | 23 |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Repatha Syringe | Evolocumab | 26 | suppressed |
| Carisoprodol | Carisoprodol | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 24 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Irbesartan | Irbesartan | 23 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 22 | suppressed |
| Vraylar | Cariprazine Hcl | 22 | suppressed |
| Folic Acid | Folic Acid | 21 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 11 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 20 | 20 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 17 |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 15 |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Entacapone | Entacapone | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Veozah | Fezolinetant | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Ciclopirox | Ciclopirox | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Dayvigo | Lemborexant | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Triazolam | Triazolam | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Nexlizet | Bempedoic Acid/Ezetimibe | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | 11 |
| Bumetanide | Bumetanide | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $133.56 · 8 records | Amgen Inc. | CRYSVITA, Kerendia, NURTEC ODT, OTEZLA, REPATHA, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error